March 28, 2019
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization was honored by the Northern Kentucky Chamber of Commerce at last night's 2019 Business Impact Awards. CTI was named a finalist in the Large Business award category. This award recognizes companies that are industry leaders in their respective markets, exemplify strong business and civic leadership, community involvement, good management practices, and financial soundness, and represent NKY to the broader region by providing outstanding goods or services.
"We're honored to be chosen by the Northern Kentucky Chamber of Commerce as a finalist for this award recognizing CTI's place as a leader in the region," remarks Timothy J. Schroeder, Founder and CEO. "The nomination is a testament to our employees, their hard work, and their dedication to positively impacting the lives of critically and chronically ill patients around the world."
The annual awards program recognize businesses – small and large, new and long-standing – impacting the Northern Kentucky community through innovation, creativity, strong business practices, and leadership. CTI was awarded a Business Impact Award in the Vision category in 2018.
CTI has been working for two decades in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa, specializing in clinical research programs involving critically ill patient populations, and has more than 30 offices worldwide to serve more than 120 pharmaceutical, biotechnology, and medical device clients. The company moved their global corporate headquarters to Northern Kentucky in 2017.